International Cannabis Weekly: 146

• Global cannabis industry moves online at Prohibition Partners LIVE.
• Canada’s cannabis sector is hiring 600 people per week despite lockdown.
• Costa Rican president announces his government will support legal hemp cultivation.
• Cannabis research driving reform efforts globally.

• Aphria subsidiary ASG Pharma receives EU GMP certification in Malta.
• European drug report shows consumers are moving to the darknet under lockdown.
• Danish medical cannabis patient numbers fell in the final quarter of 2019.
• European cannabis report says Europe is moving towards a unified single market.
• New cannabis research facility planned for the Isle of Wight.
• European consortium to submit a consolidated Novel Food application.
• Experts warn that a lack of safety data could undermine the British CBD industry.

• Ontario extends roadside pickup and delivery provisions for cannabis retailers.
• New Brunswick resumes evaluations for adult-use retail system.
• Aleafia Health secures Health Canada licence for expansion of Paris, Ontario facility.

• Joe Biden includes cannabis decriminalisation in newly released social justice plan.
• Cannabis sales fluctuate unevenly in US states as COVID-19 disrupts the industry.
• Oklahoma’s medical cannabis dispensaries see record sales in April.
• California cannabis reform efforts on hold as lawmakers tackle COVID-19 relief.
• Pennsylvania poll finds nearly two-thirds of likely voters support legalising cannabis.

• Australian medical cannabis prescriptions remain steady during lockdown.
• Novel medical cannabis wafers made available to select patients in Queensland.
• NZ Drug Foundation says the THC limit in proposed cannabis regulations is too high.
• MediPharm Labs Australia signs its second international white-label supply deal.

• US Virgin Islands minister says food security a priority but cannabis reform will come.
• Avicanna to export 100,000 cannabis seeds to the US.
• Jamaican CBD producer says its raised US$1 million to expand local facility.

• Israeli cannabis firms post disappointing financial results as exports remain delayed.
• Labat Africa releases upbeat 2021 and 2022 financial year forecasts.
• South African group signs letter of intent with US firm to develop cannabis technology.

• Multiple sclerosis study finds cannabis may aid more than just spasticity symptoms.
• Researchers develop new oxidation test for cannabis breathalysers.
• Cannabis shows early promise as an adjunct therapy in COVID-19 infection study.

• New York lawmaker introduces a bill to decriminalise psilocybin.
• Champignon Brands appoints Pat McCutcheon to company board of directors.
• MindMed raises US$10 million to fund research collaboration.
• Molecular Science Corp. receives GMP licence from Health Canada.

Find out more at partnerships@prohibitionpartners.com.